Tevogen Bio Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tevogen Bio Holdings Inc. (TVGN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Current Assets
Cash and Cash Equivalents1.281.055.487.12
Cash & Short-Term Investments1.281.055.487.12
Accounts Receivable0.160.000.000.00
Inventory0.000.000.000.00
Other Current Assets0.920.670.350.05
Total Current Assets2.361.725.847.17
Non-Current Assets
Property, Plant & Equipment (Net)0.520.931.310.14
Other Non-Current Assets0.580.270.590.34
Total Non-Current Assets1.103.78356.860.49
Total Assets3.465.517.747.66
Current Liabilities
Accounts Payable5.203.420.870.38
Short-Term Debt1.8880.710.000.00
Current Portion of Long-Term Debt0.0080.710.000.00
Accrued Liabilities1.560.980.580.24
Other Current Liabilities1.960.120.240.05
Total Current Liabilities9.0485.481.960.67
Non-Current Liabilities
Long-Term Debt1.0114.2239.3023.48
Other Non-Current Liabilities0.090.000.000.00
Total Non-Current Liabilities1.0914.4514.7123.48
Total Liabilities10.1499.9341.6924.15
Stockholders' Equity
Common Stock0.020.010.060.06
Retained Earnings-113.39-99.66-39.18-17.14
Additional Paid-in Capital97.895.225.170.59
Shares Outstanding177.99165.42158.11158.11
Total Stockholders' Equity-6.67-94.43-33.95-16.49
Total Liabilities & Equity3.465.51357.147.66